Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04103931 · ClinicalTrials.gov registry record · NA
Impact of a Patient Decision Aid for Treatment of Aortic Stenosis
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT04103931: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04103931 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 67 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04103931, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
This project will evaluate the impact of a patient decision aid created by the American College of Cardiology for patients considering treatment of aortic stenosis. The decision aid describes surgical aortic valve replacement (SAVR) surgery and transcatheter valve replacement surgery (TAVR).
Interventions
- BEHAVIORAL "Treatment Choices for Aortic Stenosis" Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2021-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04103931
The ClinicalTrials.gov registry entry for NCT04103931 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which "Treatment Choices for Aortic Stenosis" Decision Aid is the first listed.
NCT04103931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04103931 about?
NCT04103931 is a clinical study titled "Impact of a Patient Decision Aid for Treatment of Aortic Stenosis". This project will evaluate the impact of a patient decision aid created by the American College of Cardiology for patients considering treatment of aortic stenosis. The decision aid describes surgical aortic valve replacement (SAVR) surgery and transcatheter valve replacement surgery (TAVR).
What is the current status of trial NCT04103931?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2019-09-23. Estimated completion is 2021-09-01.
What interventions are being tested in trial NCT04103931?
The interventions under investigation include: "Treatment Choices for Aortic Stenosis" Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT04103931?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.